CSF2 and Parkinson disease: Furthermore, GM-CSF treatment results in increased frequencies of Tregs and Treg function suggesting that immune modulation with GM-CSF upregulates Treg-mediated immune regulation that is significantly diminished in PD patients and provides an efficacious therapeutic strategy (Saunders et al., 2012; Gendelman et al., 2017).